CannabisLink.ca - Top Stories

Top Stories (2026) - (1734 items)

(All links open in new tab)

Oct 20, 2026	Recent Studies Debunk Anti-Cannabis Industry Talking Points A trio of recent studies provides evidence that directly contradicts major talking points that are often used by special interests opposed to the legal cannabis industry. The first pertains to crime, the second to youth cannabis consumption, and the third to motor vehicle safety. Cannabis industry opponents frequently make the claim that if legal cannabis sales are permitted, a spike in crime will occur in the area surrounding where legal sales are allowed. A researcher at Brock University examined crime data in Toronto and Ottawa, where adult-use cannabis sales are legal. His findings were published in The International Journal of Drug Policy.
Oct 20, 2026	Trump losing ground with cannabis consumers ahead of midterms Cannabis consumers are increasingly dissatisfied with the Trump administration’s handling of marijuana policy. A recent poll shows major declines among the demographic, as advocates continue to wait for broader reform and a hemp ban looms. The survey from NuggMD and Marijuana Moment revealed that 29 percent of cannabis consumers either approve or strongly approve of the administration’s actions on the plant. That’s a major drop from the July quarterly poll, when support was 48 percent.
Oct 20, 2026	Opening Legal Marijuana Dispensaries Provides An Economic Boost For Nearby Businesses, Study Shows The opening of recreational marijuana dispensaries can help boost nearby businesses by increasing foot traffic, purchases and revenue, according to a new study. Researchers from the City University of New York, Northern Illinois University and University of Miami examined cannabis market growth, credit and debit card purchases and socioeconomic and demographic data in Illinois from 2021 through 2024, finding that “recreational dispensary openings increase the number of customers at nearby establishments by approximately 6.82%, transactions by 8.01%, and revenue by 7.47%.”
Oct 19, 2026	Study Finds THC-Rich Marijuana Extracts Trigger Leukemia Cell Death and Immune-Response Signals THC-rich marijuana extracts triggered programmed cell death in leukemia cells while activating biological signals associated with immune recognition of cancer, according to new research accepted for publication in Frontiers in Immunology. The study, conducted by researchers affiliated with the Juan N. Corpas University Foundation in Bogotá, Colombia, examined how marijuana extracts with different THC and CBD concentrations affected two human leukemia cell lines and the activity of immune cells known as macrophages.
Oct 19, 2026	Legal Retailers Welcome Ontario’s Plan to Target Illegal Cannabis Shops The Ontario government says it plans to strengthen enforcement against illegal cannabis sales in the province. The proposed changes will be part of an upcoming legislative package. They would give the Alcohol and Gaming Commission of Ontario (AGCO) new tools to address unauthorized cannabis storefronts and unlawful online retail operations, including the authority to conduct inspections, seize illegal cannabis products and equipment, and issue administrative monetary penalties.
Oct 19, 2026	NORML Files Amicus Brief in Case Over Enforceability of Cannabis-Related Contracts Members of the NORML Legal Committee – led by attorney William Swor of Detroit, Michigan – have filed a friend-of-the-court (amicus) brief urging the US Court of Appeals for the Sixth Circuit to reconsider its decision that cannabis industry contracts are not enforceable as long as marijuana is federally prohibited. Specifically, the Appeals Court ruled in September that federal courts cannot award breach-of-contract damages in situations that enforce an agreement specific to conduct that is prohibited by the US Controlled Substances Act.
Oct 19, 2026	European Cannabis at the Crossroads: Regulation Across Borders The 2026 report from the European Union Drugs Agency (EUDA) highlights that cannabis policies in Europe are evolving at varying rates and in different directions. Germany, Malta and Spain have established different frameworks for adult-use cannabis; Luxembourg and Czechia have introduced limited home cultivation, while the Netherlands is testing regulated cannabis supply. At the same time, other countries maintain much more restrictive approaches.
Oct 19, 2026	Here’s the Hands-Down Best Cannabis Stock for Dividend Investors Many income investors wouldn't go near a pot stock with a 10-foot pole -- and for good reason. For one thing, most cannabis stocks don't pay dividends. The ones that do operate in a highly volatile industry. However, it's important to remember the adage "don't throw the baby out with the bath water." Sure, most cannabis stocks aren't good picks if you're seeking reliable income. There's one, though, that I think is hands-down the best cannabis stock for dividend investors. If you want cannabis exposure without cannabis-company risk, along with an exceptionally juicy yield, check out Innovative Industrial Properties 9.00% Series A Cumulative Redeemable Preferred Stock (NYSE: IIPR-PA).
Oct 19, 2026	Curaleaf Continues Fight After Raising Takeover Bid for Aurora Cannabis Curaleaf today responded to Aurora Cannabis recommending that its shareholders reject Curaleaf's increased takeover proposal, extending the companies' public battle over a potential deal. "Aurora's Board has a fiduciary duty to shareholders, which requires it not to take illogical steps to keep the highest bidder out of the room. The board has locked out Curaleaf while granting diligence access to unnamed parties and cites selective sources to support its agenda. None of that reflects a board acting in the company's or shareholders' best interests. Shareholders deserve the facts, and the facts favor engagement, not obstruction," said Curaleaf CEO Boris Jordan in a statement.
Oct 19, 2026	Devils on the loose: The deadly cost of Kanehsatà:ke’s cannabis boom The cannabis industry is booming here and it has transformed the community into a volatile battleground. What started with a single unlicensed shop in 2018 has exploded into roughly 30 dispensaries, including megastores and casinos lining the main thoroughfare. Some play loud music all day, light up the night sky with neon and attract massive crowds. Even rapper Snoop Dogg performed here two years ago.
Oct 19, 2026	Cannabis is getting stronger, but doubling THC dose doesn’t get you twice as ‘high’ – new study Cannabis products are getting more potent and easier to buy around the world. Yet little is known about how bigger doses of tetrahydrocannabinol (THC), the main active ingredient in cannabis, change what people feel. Our new research found that larger doses generally make people feel more high, but not in a straight line. Doubling the dose does not double the feeling of intoxication.
Oct 19, 2026	Bolsonaro vs. Lula: Brazil’s Runoff Could Decide Who Profits From Cannabis in a Country of 200 Million Flávio Bolsonaro, son of former President Jair Bolsonaro, edged Lula in the first round and has named a cannabis executive as his pick for health minister. With the October 25 runoff days away, Brazil’s patient associations fear a market built for corporations, while investors see an opening in Latin America’s biggest economy.
Oct 19, 2026	Uganda’s new hemp and medical cannabis cooperative aims to organize farmers, investors A newly established cooperative in Uganda is seeking to organize farmers and attract investment in industrial hemp and medical cannabis. The Uganda Medical Cannabis and Industrial Hemp Cooperative Society (UMCHICS) is intended to connect licensed producers, investors and government institutions while establishing standards for product quality, traceability and regulatory compliance. At a meeting in Kampala in early October, government officials acknowledged the economic potential of the two crops while warning that licensed operators face penalties for diverting cannabis into illegal markets.
Oct 19, 2026	What Canada’s Cannabis Shelves Teach About Grading Every maturing market ends up with a cheap tier and a premium tier. The hard part is proving the premium tier deserves its price. Canada’s legal cannabis market offers an unusual case, because its top grades have no official standard behind them. In Canada, legal since 2018, adults can buy top shelf bud from curated craft ranges that sellers rank above everyday stock. This is information, not an invitation to buy, and the legal age is 19 in most provinces, 18 in Alberta and 21 in Quebec. These sellers ship within Canada only, so readers in Nigeria and across Africa cannot order. Cannabis also remains illegal in Nigeria, and rules differ from country to country. Treat this as a business case for adult readers, not health guidance.
Oct 19, 2026	Cannabis formulation reduces morphine use by nearly half in clinical trial A cannabis-based medicine significantly reduced morphine use among hospital patients with severe nerve-related pain, according to the results of a new clinical trial. The study, published in the Journal of Cannabis Research, found that patients given a higher dose of cannabis used 47.6% less morphine over 24 hours than those given a placebo. Despite receiving considerably less morphine, patients in the cannabinoid group did not report significantly higher pain levels, suggesting that cannabis-based medicines could potentially reduce the amount of opioid medication required to manage acute pain.
Oct 19, 2026	Do THC And CBD Degrade Over Time At Room Temperature? “To maximize cannabinoid shelf-life and prevent degradation, storage temperatures must match product composition. While CBD-dominant products can tolerate room-temperature storage, THC-rich products require cold chain management, ideally stored in a freezer at -20°C for optimal long-term potency.” the researchers concluded.
Oct 19, 2026	Morocco's exports of legal cannabis have expanded to 15 countries Morocco's legal cannabis industry is expanding its international presence, with cannabis resin exports now reaching 15 countries, including France, Switzerland, Portugal, Luxembourg, the Czech Republic, Australia, and South Africa. As the kingdom seeks to establish itself in the global market for cannabis-derived products, its 2026 harvest comes amid stricter regulatory controls as well as a commitment to protecting the identity of its cannabis abroad.
Oct 18, 2026	Why Is Marijuana Regulated More Strictly Than Alcohol, Even Though It Is Safer To Use? (Op-Ed) I read the commentary piece by Robert Mellion, executive director of the Massachusetts Package Stores Association, with great bemusement. He argues that oversight of the state’s cannabis sector has been lax and that it should be regulated like alcohol. I think he has it backwards in two fundamental ways. First, alcohol is a much more deadly intoxicant than cannabis. Full stop. It’s worth wondering out loud whether alcohol and cannabis should have the same regulatory regime. Under the existing legal cannabis industry, there have been zero reported deaths from legal cannabis use. The same is not true of alcohol use. Second, cannabis is regulated more comprehensively than virtually any other retail product sold in Massachusetts.
Oct 17, 2026	First cannabis market study in Missouri finds that legal sales are thriving The first state-funded study since cannabis was legalized for recreational use in November 2022 found that Missouri’s regulated market has captured 93% of all marijuana transactions, and sales are evenly distributed across the state. The study also found that most consumers purchase flower or “weed” rather than alternatives, and monthly expenditures among all cannabis products averages $161.18 per consumer. Their purchasing decisions are largely driven by price, convenience and strength of the psychoactive substance THC, according to the study results. Overall, the study concluded that the cannabis market is stable and consumers are satisfied with the legal supply available in the state.
Oct 17, 2026	The first plant-based medical THC spray arrives in the United Kingdom The Irish pharmaceutical laboratory Dunbar Pharma launches the country's first plant-based THC mouth spray. Made by its British partner IPS Pharma, this new formulation offers an additional administration option to medical specialists, just two months after the launch of THC capsules by the two companies.
Oct 17, 2026	Moroccan tycoon Lamia Tazi's Sothema wins approval for three cannabis epilepsy drugs Moroccan pharmaceutical tycoon Lamia Tazi's Sothema, the Casablanca-listed drugmaker controlled by the Tazi and Berrada families, has won marketing authorisations for three cannabis-based medicines to treat epilepsy, its first approvals in the medical cannabis business it has been building for the past several years. The drugs were developed with the Fondation Mohammed VI des Sciences et de la Santé, a Moroccan health and research foundation. None of them is on sale in Morocco yet. Sothema has not disclosed their brand names, formulations, prices or launch dates, or whether the national health insurance scheme will reimburse them.
Oct 17, 2026	OPINION: Canada’s legal cannabis system has an access problem hiding in plain sight Eight years after cannabis legalization, Canadians seeking CBD for health-related reasons are still caught between two systems that weren’t built for them. In the recreational market, non-intoxicating products and the people looking for them have been squeezed to the margins of a retail system that rewards high THC and fast sales. Shelf space goes to what moves: an August 2026 review of Ontario’s cannabis catalogue found that just 1.2% of listings were THC-free. OCS data also shows that roughly 80% of new listings are phased out within a year.
Oct 17, 2026	Medical Cannabis in Germany: THC Prices Vary by a Factor of 12 The price of medical cannabis in Germany varies considerably depending on the formulation: one milligram of THC can cost between €0.12 and €1.40. A new comparative study conducted by the Working Group on Medical Cannabis (Working Group on Cannabis as Medicine – ACM) highlights substantial differences between approved drugs, cannabis extracts, and compounding preparations.
Oct 16, 2026	Eight Years of Legalization: Canada’s Abandoned Cannabis Policy and Unfinished Industry The federal government has abandoned cannabis. Not only the industry, but the policy itself. In the lead-up to legalization on October 17, 2018, there was enormous political will and momentum to approach legalization through a public-health lens. But almost immediately after the law took effect, that momentum quickly began to wither.
Oct 16, 2026	Why Cannabis Stocks Are Looking Dirt Cheap What does cannabis have to do with disruptive technology investing? Many people ask that question when they see we cover cannabis alongside more than 50 disruptive technology themes. Cannabis is neither a technology nor disruptive, though some might argue it disrupts those who consume too much of it. The backstory behind why we cover cannabis is worth telling because it surrounded the biggest hype cycle we’ve ever seen.
Oct 16, 2026	The Status of Federal Cannabis Rescheduling On December 18, 2025 President Trump signed an executive order directing federal agencies to begin expediting the process of rescheduling marijuana from Schedule I to Schedule III under the Controlled Substances Act.[1] This decision follows years of federal review and empty promises from multiple administrations as medical and retail sales of marijuana have expanded to 40 states and the District of Columbia. Updates since Trump’s announcement have been sparse.
Oct 16, 2026	Most Pre-Rolls Suck. Josh Kesselman Thinks He Found the Fix, and He Wants the Industry to Copy Him. Three people who judge cannabis for a living were asked separately what’s wrong with the pre-roll aisle. None knew what the others had said. They landed in almost exactly the same place. Then one of them built a fix and published it so his competitors could steal it.
Oct 16, 2026	Kentucky Now Has Medical Marijuana Dispensaries Open In Every Region Of The State, Governor Announces The governor of Kentucky announced on Friday that medical marijuana dispensaries are now open across all 11 licensing regions of the state following the opening of Sunnyside Dispensary in Floyd County this week. “Kentuckians suffering from PTSD, cancer, terminal illnesses, sickle cell anemia and more deserve a safe, non-addictive option for relief, and medical cannabis provides that,” Gov. Andy Beshear (D) said.
Oct 16, 2026	Morocco revokes 1,490 cannabis licenses amid 2026 harvest and European market push Morocco's National Agency for the Regulation of Cannabis-Related Activities has revoked 1,490 licenses tied to the country's legal cannabis sector for noncompliance with applicable procedures and regulations, as the 2026 harvest moves forward across the country's three regulated provinces. Of the total licenses withdrawn, nearly 1,300 belonged to cannabis growers and 190 to other operators across the supply chain. The 190 non-grower licenses cover seed imports (60), processing and manufacturing (45), marketing (35), exports (31), seed exports (12) and transportation (7).
Oct 15, 2026	Cannabis and Health: How Cannabinoids Affect the Human Body Introduction Researchers are increasingly exploring cannabinoids as bioactive dietary compounds with potential applications in nutrition and health. As research into hemp-derived ingredients expands, scientists are investigating how non-intoxicating cannabinoids interact with the endocannabinoid system (ECS) and other signaling pathways to influence metabolism, inflammation, and disease.2,3
Oct 15, 2026	France already has 3,000 cannabis retail outlets. None of them are legal. France has thousands of drug dealing spots, five million annual cannabis users, and a market worth several billion euros. Yet the sale of cannabis to adults remains illegal. This paradox is reflected in the official figures. According to the Mapping of the Drug Trade in France in 2024 According to government data, there were approximately 3,000 points of sale across the country. This figure includes all types of narcotics, not just cannabis, but it gives an idea of the scale of the distribution networks.
Oct 15, 2026	Chile’s Cannabis Social Clubs Are Booming In A Legal Gray Area Cannabis social clubs are taking off across Chile, yet they continue to operate in a precarious legal gray area that leaves their future hanging in the balance. Over the past decade, the number of registered cannabis social clubs shot up to at least 294 by late 2024, spread across all 16 regions of the South American country, according to a study published in the Journal of Cannabis Research in September. Although 67.3% of these clubs are concentrated in the Santiago Metropolitan Region, 2024 alone saw a record 71 new registrations nationwide—most of them in Santiago and Las Condes.
Oct 15, 2026	Competing Canadian Trademark Filings Spark Brand Name Dispute Over Cannabis Products Sidekick Analytics, an independent cannabis product developer and brand owner based in Ontario, is involved in a priority battle with multinational consumer packaged goods company Tilray Brands Inc. over conflicting claims to the PORTALS brand name. Dan Black launched the PORTALS brand under Sidekick Analytics and managed its formulation, compliance, packaging, and sales. By 2023, PORTALS-branded products, including tablets and edibles, were sold commercially in Ontario, BC, and Alberta, generating what he says was nearly $3 million in retail sales.
Oct 15, 2026	Marijuana Is A Popular Tool For People Trying To Quit Smoking Cigarettes, Rivaling Prescription Nicotine Cessation Medications, Study Shows Almost as many people are using marijuana to help them quit smoking cigarettes as are using prescription nicotine cessation aids, according to a new study conducted by officials with the U.S. Department of Veterans Affairs (VA) and other institutions. The research, however, raises questions about potential side effects experienced by people who are using cannabis to quit tobacco products.
Oct 15, 2026	Nearly one-third of cannabis consumers say they have completely cut out alcohol Nearly one-third of cannabis consumers say they have completely replaced alcohol with cannabis, while almost two-thirds report drinking less as a result of their cannabis use, according to a new survey conducted in the United States. The poll was conducted as part of Sober October, an annual initiative encouraging people to abstain from alcohol for a month, by medical cannabis telehealth company NuggMD. Over 1000 cannabis consumers were polled between 24 and 26 September 2026.
Oct 15, 2026	Cronos Completes Acquisition of CanAdelaar, Europe’s Largest Adult-Use Cannabis Company TORONTO, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company"), an innovative global cannabis company, today announced that it has completed its previously announced acquisition of CanAdelaar B.V. ("CanAdelaar"), the largest cannabis company operating within the Netherlands' adult-use cannabis pilot program, the Wietexperiment.
Oct 15, 2026	Irradiated Medical Cannabis and the Science Behind the Debate Much of the discussion involving irradiated medical cannabis centres on whether the treatment affects THC or terpenes. Those are reasonable questions, but I think the microbiology deserves an equal share of the attention. Irradiation can substantially reduce the number of viable microorganisms in flower, but any mould that has already grown remains physically present after treatment.
Oct 15, 2026	Cannabis doesn’t make you violent – despite what recent reports have claimed n what looked like a return to the dark days of Reefer Madness – a 1936 film that portrayed cannabis as a drug that could drive people to madness and murder – a recent article in the Daily Telegraph claimed that cannabis users are “twice as likely to be violent”. The claim comes from a systematic review by King’s College London that combined 63 studies covering more than 265,000 people. The researchers did, indeed, find a link between cannabis use and violence, but the headline overstates what the numbers can tell us. There are three reasons to be cautious: other factors that could explain the link (known as confounders), the way the studies were designed, and potential biases in how the data was gathered.
Oct 14, 2026	Tilray Medical Facility in Portugal Gains Approval for In-House Testing Portugal’s National Authority of Medicines and Health Products has approved the quality control laboratory at Tilray Medical’s EU-GMP-certified facility in Cantanhede, Portugal, to conduct microbiological and chemical/physical testing in-house. The company says the INFARMED approval gives Tilray Medical greater control over critical quality testing, accelerates product release capabilities, and strengthens its Portugal facility as a strategic launchpad for medical cannabis supply across regulated international markets.
Oct 14, 2026	New cannabis packaging business launches in Canada CropPak has launched a new cannabis packaging company and website created specifically for cannabis growers and brands. The launch marks the start of operations for the Abbotsford-based business, which was established around a factory-direct packaging model intended to help cultivators manage packaging expenses as tighter operating margins increase the importance of cost control.
Oct 14, 2026	Herbal Dispatch Ships 3,000 Units of 2026 Happy Hour Holiday Cannabis Calendar to BCLDB Following Sold-Out 2025 Edition Herbal Dispatch (LUFFF) sold and shipped 3,000 units of its 2026 Happy Hour Holiday Cannabis Calendar to the British Columbia Liquor Distribution Branch. The shipment represents over $100,000 in wholesale sales at $34.99 per unit, with an approximate gross margin of 42%. Produced with Coast Mountain Cannabis, the Calendar will reach BC Cannabis Stores and private licensed retailers. Production increased to 4,200 units, about 25% above the sold-out 2025 run of 3,350 units.
Oct 14, 2026	Aurora Cannabis Reaffirms Recommendation to Shareholders: REJECT Curaleaf's Revised Hostile Bid; Preserve Opportunities for Future Upside EDMONTON, AB, Oct. 14, 2026 /CNW/ -- Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NASDAQ: ACB), the Canadian-based leading global medical cannabis company, today reconfirms that the Board of Directors (the "Board"), on the unanimous recommendation of a special committee of independent directors (the "Special Committee"), unanimously recommends that shareholders REJECT the hostile offer by Curaleaf Holdings, Inc. ("Curaleaf") (TSX: CURA) (OTCQX: CURLF) for all of the issued and outstanding common shares of the Company, as revised in the Notice of Variation, Change and Extension filed by Curaleaf on October 6, 2026 (the "Hostile Bid"). "Curaleaf's revised offer still does not reflect the value of the company Aurora shareholders own today. Aurora is debt-free with a strong cash position, and we believe the revised Hostile Bid continues to ask shareholders to give up that strength, and their future upside, at a discount," said Miguel Martin, Executive Chairman and CEO of Aurora.
Oct 14, 2026	German Organizations Criticize Changes To Cannabis Flower Reimbursements This month, the Health Committee of the German Bundestag held a hearing to discuss the coalition’s proposed amendments to the Statutory Health Insurance (SHI) Contribution Rate Stabilization Act. The measure was approved before the Bundestag’s summer recess. The German Hemp Association (DHV) issued a statement leading up to the recent Health Committee hearing.
Oct 14, 2026	The Aurora Ménage à Trois: Three Shifts in Seven Days Curaleaf Holdings’ battle to acquire Aurora Cannabis has shifted in favour of the Canadian producer on multiple fronts over the last week. Not only has Curaleaf raised its hostile bid by 25% to an implied US$5.00 per share, but media reports suggest the BAT-backed (British American Tobacco) Organigram Global is now also in contention to merge with Aurora. Alongside the completion of a major expansion of its German EU-GMP facility expected to double its annual flower production, Aurora is now in a considerably stronger position than just a week earlier.
Oct 14, 2026	Cannabis prices down $1 to date in 2026 Cannabis prices hit a new low in September, falling to an average $6.57 per gram. Total sales in both the adult-use and medical markets also fell between August and September. The average price per gram of marijuana has fallen by just over a dollar in 2026. In January, marijuana averaged $7.63 a gram. Prices have generally fallen each month, except between April and May where the price per gram increased by nine cents. Marijuana prices peaked in March 2024, at an average $12.51 per gram and have largely fallen month-over-month since. The average price per adult-use product has also followed the same trend. In September, the average adult-use product cost $27.24, down from $28.09 the previous month.
Oct 14, 2026	Why Aurora Cannabis (TSX:ACB) Is Defending Its Medical Cannabis Strategy Against Curaleaf's Revised Bid Aurora Cannabis Inc. (TSX:ACB) is in the spotlight because it is defending against a hostile take-over bid from Curaleaf Holdings, Inc., which was revised in early October to an offer that Curaleaf values at US$5.00 per Aurora share. Aurora's board had said it would give a formal recommendation on the revised terms after its special committee reviews them. In the meantime it has told shareholders to take no action. The company's case for independence rests on a debt-free balance sheet, a growing international medical cannabis business and EU-GMP certified production capacity.
Oct 13, 2026	Puerto Rico Rolls Back Workplace Protections for Medical Cannabis Patients. Who’s Left Out? Puerto Rico’s new Act 204-2026 creates an exception to workplace protections for registered medical cannabis patients in certain safety-sensitive transportation roles. The law does not eliminate the medical cannabis program or protections for patients generally, but it gives employers a new legal basis for employment decisions involving covered workers.
Oct 13, 2026	Clinical Trials Begin in U.S. for First Cannabis-Based Medicine for Chronic Pain The first clinical trials in the United States for a cannabis-based medicine for chronic pain are getting underway. New York State has authorized a clinical trial of VER-01 in patients with chronic low back pain from lumbosacral radiculopathy, commonly known as sciatica. VER-01 was developed by Vertanical, a German biopharmaceutical company, and recently became available by prescription in Europe, where it is sold under the brand name Exilby. Exilby is a full spectrum extract derived from THC, CBD and terpenes found in cannabis sativa. Unlike other cannabis-based medicines already on the market, such as Epidolex and Marinol, which are used to treat epilepsy and improve appetite, Exilby was specifically developed to treat chronic pain.
Oct 13, 2026	Canadian cannabis company Organigram enters fight for Aurora The fight to acquire Aurora Cannabis may include a global tobacco giant. In a signal that Curaleaf Holdings’ hostile takeover bid could be undercut, Organigram Holdings, a Canadian licensed producer partly owned by British American Tobacco, is also interested in acquiring Aurora, cannabis newsletter Cultivated reported.
Oct 13, 2026	How Many U.S. Adults Consume Cannabis? A team of researchers affiliated with the U.S. National Institutes of Health recently conducted a study examining, among other things, the rate of cannabis use by adults in the United States. The study’s findings were published in the journal Addictive Behaviors. The study used data from the 2024 Health Information National Trends Survey, which asked about past 12-month cannabis use. The survey also asked about which consumption method cannabis consumers used, such as smoking, vaping, dabbing, edibles, drinkables, and topicals. The study also asked about tobacco use. “An estimated 23.1% of US adults reported past 12-month cannabis use: 62.6% smoked, 57.6% consumed, 40.1% vaped, 15.2% applied lotion, and 12.4% dabbed, with over half (52.7%) endorsing >1 route of administration.” the study found.

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35